Sparking a renewed interest in an established treatment
The cardiovascular treatment and prevention pathway is well established, but with relatively little innovation, keeping treatments front of mind was challenging. There is a grey area in current risk reduction guidelines, where clinicians require more guidance when making prescribing decisions.